For the full year 2024, Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies, delivered revenues of NOK 531.3, which is 3.8 per ...

D illustration of bacteriaphages attacking bacteria. Courtesy Getty Images.In the face of rising concerns about antibiotic ...

"Conducting research through the SEA-PHAGES program was the first time in my academic career where I felt what I learned in ...

The Harvard Pilgrim Health Care Institute is proud to announce the launch of the Center for Sepsis Epidemiology and ...

Today the Coalition for Epidemic Preparedness Innovations (CEPI) announced an award of $5 million funding award to Ethris, a ...

Pearl Diagnostics will receive $1 million to evaluate the potential of a prototype assay for early detection of pneumonia caused by Pseudomonas aeruginosa.

Emblaveo marks the first and only fixed-dose intravenous monobactam/β-lactamase inhibitor combination antibiotic to be ...

Antimicrobial resistance is a growing health crisis that could lead to millions of deaths by 2050, according to the World ...

Researchers have found in a new study that common antibiotic Vancomycin may also be effective in treating individuals with a ...

Anterior Cruciate Ligament Reconstruction Improves Functional Scores and Quality of Life in Patients Older than 50 Years of ...

AbbVie has announced that the US Food and Drug Administration (FDA) has approved its Pfizer-partnered Emblaveo ...

Photodynamic inactivation using curcumin shows promise in reducing antibiotic resistance diversity in Staphylococcus aureus, ...